# Q2 Holdings, Inc.: financial statements, quarterly

QTWO · NYSE · CIK 1410384 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qtwo.md) · [Financials](/companies/qtwo/financials.md) · [Filings](/companies/qtwo/filings.md) · [Insiders](/companies/qtwo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qtwo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [155](/filings/0001410384-24-000197.md) | [162 d](/filings/0001410384-26-000006.md) | [166](/filings/0001410384-25-000094.md) | [173](/filings/0001410384-25-000138.md) | [175](/filings/0001410384-25-000159.md) | [183 d](/filings/0001410384-26-000006.md) | [190](/filings/0001410384-26-000037.md) | [195](/filings/0001410384-26-000053.md) | [202](/filings/0001410384-25-000159.md) | [208 d](/filings/0001410384-26-000006.md) | [217](/filings/0001410384-26-000037.md) | [220](/filings/0001410384-26-000053.md) |
| Cost of revenue | $m | [80.8](/filings/0001410384-24-000197.md) | [80.7 d](/filings/0001410384-25-000010.md) | [83.3](/filings/0001410384-24-000099.md) | [86.1](/filings/0001410384-24-000160.md) | [86.0](/filings/0001410384-24-000197.md) | [86.7 d](/filings/0001410384-25-000010.md) | [88.7](/filings/0001410384-26-000037.md) | [90.6](/filings/0001410384-26-000053.md) | [92.9](/filings/0001410384-25-000159.md) | [92.9 d](/filings/0001410384-26-000006.md) | [88.6](/filings/0001410384-26-000037.md) | [89.6](/filings/0001410384-26-000053.md) |
| Gross profit | $m | [74.1](/filings/0001410384-24-000197.md) | [81.4 d](/filings/0001410384-26-000006.md) | [82.3](/filings/0001410384-25-000094.md) | [86.8](/filings/0001410384-25-000138.md) | [89.1](/filings/0001410384-25-000159.md) | [96.3 d](/filings/0001410384-26-000006.md) | [101](/filings/0001410384-26-000037.md) | [105](/filings/0001410384-26-000053.md) | [109](/filings/0001410384-25-000159.md) | [115 d](/filings/0001410384-26-000006.md) | [128](/filings/0001410384-26-000037.md) | [130](/filings/0001410384-26-000053.md) |
| Research and development | $m | [34.5](/filings/0001410384-24-000197.md) | [34.3 d](/filings/0001410384-26-000006.md) | [34.9](/filings/0001410384-25-000094.md) | [35.8](/filings/0001410384-25-000138.md) | [36.9](/filings/0001410384-25-000159.md) | [35.7 d](/filings/0001410384-26-000006.md) | [37.9](/filings/0001410384-26-000037.md) | [36.9](/filings/0001410384-26-000053.md) | [38.9](/filings/0001410384-25-000159.md) | [40.6 d](/filings/0001410384-26-000006.md) | [41.9](/filings/0001410384-26-000037.md) | [41.1](/filings/0001410384-26-000053.md) |
| Operating income | $m | [(23.2)](/filings/0001410384-24-000197.md) | [(18.0) d](/filings/0001410384-26-000006.md) | [(14.2)](/filings/0001410384-25-000094.md) | [(13.7)](/filings/0001410384-25-000138.md) | [(12.8)](/filings/0001410384-25-000159.md) | [(1.6) d](/filings/0001410384-26-000006.md) | [2.2](/filings/0001410384-26-000037.md) | [9.8](/filings/0001410384-26-000053.md) | [11.0](/filings/0001410384-25-000159.md) | [16.9 d](/filings/0001410384-26-000006.md) | [27.7](/filings/0001410384-26-000037.md) | [29.3](/filings/0001410384-26-000053.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [1.3](/filings/0001410384-26-000037.md) | [1.3](/filings/0001410384-26-000053.md) | not reported | not reported | [1.0](/filings/0001410384-26-000037.md) | [0.8](/filings/0001410384-26-000053.md) |
| Income tax | $m | [1.0](/filings/0001410384-24-000197.md) | [2.1 d](/filings/0001410384-26-000006.md) | [1.6](/filings/0001410384-25-000094.md) | [2.1](/filings/0001410384-25-000138.md) | [2.3](/filings/0001410384-25-000159.md) | [1.8 d](/filings/0001410384-26-000006.md) | [0.5](/filings/0001410384-26-000037.md) | [1.7](/filings/0001410384-26-000053.md) | [0.2](/filings/0001410384-25-000159.md) | [0.3 d](/filings/0001410384-26-000006.md) | [3.1](/filings/0001410384-26-000037.md) | [1.9](/filings/0001410384-26-000053.md) |
| Net income | $m | [(23.2)](/filings/0001410384-24-000197.md) | [(18.1) d](/filings/0001410384-26-000006.md) | [(13.8)](/filings/0001410384-25-000094.md) | [(13.1)](/filings/0001410384-25-000138.md) | [(11.8)](/filings/0001410384-25-000159.md) | [0.2 d](/filings/0001410384-26-000006.md) | [4.8](/filings/0001410384-26-000037.md) | [11.8](/filings/0001410384-26-000053.md) | [15.0](/filings/0001410384-25-000159.md) | [20.4 d](/filings/0001410384-26-000006.md) | [26.6](/filings/0001410384-26-000037.md) | [29.9](/filings/0001410384-26-000053.md) |
| Diluted EPS | $ per share | [(0.40)](/filings/0001410384-24-000197.md) | not reported | [(0.23)](/filings/0001410384-25-000094.md) | [(0.22)](/filings/0001410384-25-000138.md) | [(0.20)](/filings/0001410384-25-000159.md) | not reported | [0.07](/filings/0001410384-26-000037.md) | [0.18](/filings/0001410384-26-000053.md) | [0.23](/filings/0001410384-25-000159.md) | not reported | [0.40](/filings/0001410384-26-000037.md) | [0.46](/filings/0001410384-26-000053.md) |
| Basic EPS | $ per share | [(0.40)](/filings/0001410384-24-000197.md) | not reported | [(0.23)](/filings/0001410384-25-000094.md) | [(0.22)](/filings/0001410384-25-000138.md) | [(0.20)](/filings/0001410384-25-000159.md) | not reported | [0.08](/filings/0001410384-26-000037.md) | [0.19](/filings/0001410384-26-000053.md) | [0.24](/filings/0001410384-25-000159.md) | not reported | [0.43](/filings/0001410384-26-000037.md) | [0.48](/filings/0001410384-26-000053.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [156](/filings/0001410384-23-000139.md) | [230](/filings/0001410384-25-000010.md) | [275](/filings/0001410384-24-000099.md) | [304](/filings/0001410384-24-000160.md) | [320](/filings/0001410384-24-000197.md) | [359](/filings/0001410384-26-000006.md) | [384](/filings/0001410384-25-000094.md) | [414](/filings/0001410384-25-000138.md) | [472](/filings/0001410384-25-000159.md) | [368](/filings/0001410384-26-000053.md) | [342](/filings/0001410384-26-000037.md) | [99.9](/filings/0001410384-26-000053.md) |
| Current assets | $m | [397](/filings/0001410384-23-000139.md) | [428](/filings/0001410384-25-000010.md) | [458](/filings/0001410384-24-000099.md) | [491](/filings/0001410384-24-000160.md) | [526](/filings/0001410384-24-000197.md) | [559](/filings/0001410384-26-000006.md) | [619](/filings/0001410384-25-000094.md) | [660](/filings/0001410384-25-000138.md) | [707](/filings/0001410384-25-000159.md) | [556](/filings/0001410384-26-000053.md) | [525](/filings/0001410384-26-000037.md) | [244](/filings/0001410384-26-000053.md) |
| Total assets | $m | [1,179](/filings/0001410384-23-000139.md) | [1,201](/filings/0001410384-25-000010.md) | [1,228](/filings/0001410384-24-000099.md) | [1,249](/filings/0001410384-24-000160.md) | [1,273](/filings/0001410384-24-000197.md) | [1,295](/filings/0001410384-26-000006.md) | [1,350](/filings/0001410384-25-000094.md) | [1,385](/filings/0001410384-25-000138.md) | [1,427](/filings/0001410384-25-000159.md) | [1,276](/filings/0001410384-26-000053.md) | [1,246](/filings/0001410384-26-000037.md) | [968](/filings/0001410384-26-000053.md) |
| Current liabilities | $m | [176](/filings/0001410384-23-000139.md) | [192](/filings/0001410384-25-000010.md) | [193](/filings/0001410384-24-000099.md) | [201](/filings/0001410384-24-000160.md) | [211](/filings/0001410384-24-000197.md) | [399](/filings/0001410384-26-000006.md) | [432](/filings/0001410384-25-000094.md) | [732](/filings/0001410384-25-000138.md) | [732](/filings/0001410384-25-000159.md) | [544](/filings/0001410384-26-000053.md) | [562](/filings/0001410384-26-000037.md) | [259](/filings/0001410384-26-000053.md) |
| Total liabilities | $m | [738](/filings/0001410384-23-000139.md) | [753](/filings/0001410384-25-000010.md) | [763](/filings/0001410384-24-000099.md) | [768](/filings/0001410384-24-000160.md) | [778](/filings/0001410384-24-000197.md) | [777](/filings/0001410384-26-000006.md) | [804](/filings/0001410384-25-000094.md) | [801](/filings/0001410384-25-000138.md) | [804](/filings/0001410384-25-000159.md) | [614](/filings/0001410384-26-000053.md) | [635](/filings/0001410384-26-000037.md) | [325](/filings/0001410384-26-000053.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [441](/filings/0001410384-24-000197.md) | [448](/filings/0001410384-26-000006.md) | [465](/filings/0001410384-25-000138.md) | [481](/filings/0001410384-25-000159.md) | [495](/filings/0001410384-25-000159.md) | [518](/filings/0001410384-26-000053.md) | [545](/filings/0001410384-26-000053.md) | [584](/filings/0001410384-26-000053.md) | [623](/filings/0001410384-25-000159.md) | [662](/filings/0001410384-26-000053.md) | [612](/filings/0001410384-26-000053.md) | [643](/filings/0001410384-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.8 d](/filings/0001410384-24-000197.md) | [36.6 d](/filings/0001410384-26-000006.md) | [13.4](/filings/0001410384-25-000094.md) | [36.0 d](/filings/0001410384-25-000138.md) | [43.3 d](/filings/0001410384-25-000159.md) | [43.0 d](/filings/0001410384-26-000006.md) | [43.5](/filings/0001410384-26-000037.md) | [48.6 d](/filings/0001410384-26-000053.md) | [45.6 d](/filings/0001410384-25-000159.md) | [63.7 d](/filings/0001410384-26-000006.md) | [56.3](/filings/0001410384-26-000037.md) | [60.7 d](/filings/0001410384-26-000053.md) |
| Capital expenditure | $m | [1.3 d](/filings/0001410384-24-000197.md) | [1.1 d](/filings/0001410384-26-000006.md) | [1.4](/filings/0001410384-25-000094.md) | [1.5 d](/filings/0001410384-25-000138.md) | [2.4 d](/filings/0001410384-25-000159.md) | [1.4 d](/filings/0001410384-26-000006.md) | [0.8](/filings/0001410384-26-000037.md) | [1.3 d](/filings/0001410384-26-000053.md) | [2.7 d](/filings/0001410384-25-000159.md) | [2.0 d](/filings/0001410384-26-000006.md) | [6.6](/filings/0001410384-26-000037.md) | [1.7 d](/filings/0001410384-26-000053.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001410384-26-000037.md) | [0.0 d](/filings/0001410384-26-000053.md) | not reported | not reported | [97.2](/filings/0001410384-26-000037.md) | [22.9 d](/filings/0001410384-26-000053.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.4](/filings/0001410384-23-000139.md) | [57.9](/filings/0001410384-24-000099.md) | [58.3](/filings/0001410384-24-000160.md) | [58.5](/filings/0001410384-24-000197.md) | [59.4](/filings/0001410384-25-000094.md) | [60.2](/filings/0001410384-25-000138.md) | [60.3](/filings/0001410384-25-000159.md) | [64.8](/filings/0001410384-26-000037.md) | [69.6](/filings/0001410384-26-000053.md) | [69.9](/filings/0001410384-25-000159.md) | [67.6](/filings/0001410384-26-000037.md) | [65.4](/filings/0001410384-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 62,354,695 at 2026-07-29, from the cover of the [10-Q filed 2026-07-29](/filings/0001410384-26-000053.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.